Skip to main content
ConductScienceScienceDex

Joseph F Cotten

NIH Rank #20632
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8425620Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2025

Linked Award Amount
$784.3K
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#20,632
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Joseph F Cotten. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Joseph F Cotten as a PI. Multi-PI records show the full award amount for context.

  • 1R41GM159487-01R41
    Investigating the safety and efficacy of pillararene sulfates as novel and effective reversal agents for both steroidal and non-steroidal neuromuscular blocking agents.
    Reversal Therapeutics Inc
    $368.4K
    award amount
  • 5R21DA061215-02R21
    Xylazine and fentanyl effects on rat breathing, metabolism, and thermoregulation
    Massachusetts General Hospital
    $208.2K
    award amount
  • 5R21DA058110-02R21
    Airway compromise and skeletal muscle rigidity as toxicity contributors in synthetic opioid and methamphetamine co-administered rats
    Massachusetts General Hospital
    $207.7K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Joseph F Cotten as a PI.

Massachusetts General Hospital
MA
$415.9K
2 grants
Reversal Therapeutics Inc
MD
$368.4K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Massachusetts General Hospital
  2. 2025
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    Multi-Institutional Research
    Awards at 2 institutions

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Joseph F Cotten.

Anthony Schwartz
Reversal Therapeutics Inc
1
shared award

Explore further

Find collaborators for Joseph F Cotten

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →